(Q37143569)

18 August 2017

1 reference

title

Cannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation (English)

1 reference

18 August 2017

0 references

0 references

D De Filippis

1

1 reference

18 August 2017

A D'Amico

series ordinal

2

1 reference

18 August 2017

T Iuvone

series ordinal

3

1 reference

18 August 2017

1 May 2008

1 reference

Journal of Neuroendocrinology

18 August 2017

1 reference

18 August 2017

20 Suppl 1

1 reference

18 August 2017

20-25

1 reference

Mast cell-committed progenitors

18 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

IL-9 enhances the growth of human mast cell progenitors under stimulation with stem cell factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Lymphatic vessels in colorectal cancer and their relation with inflammatory infiltrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Cardiac chymase: pathophysiological role and therapeutic potential of chymase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Inhibition of granuloma-associated angiogenesis by controlling mast cell mediator release: role of mast cell protease-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Mast cells: a cellular link between autoantibodies and inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Chymase-positive mast cells play a role in the vascular component of airway remodeling in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Desloratadine prevents compound 48/80-induced mast cell degranulation: visualization using a vital fluorescent dye technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Tranilast reduces mesenteric vascular collagen deposition and chymase-positive mast cells in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Targeting kit activation: a potential therapeutic approach in the treatment of allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Biochemistry of the endogenous ligands of cannabinoid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Cannabidiol--recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Human mast cells take up and hydrolyze anandamide under the control of 5-lipoxygenase and do not express cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Opposing control of cannabinoid receptor stimulation on amyloid-beta-induced reactive gliosis: in vitro and in vivo evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Differential roles of CB1 and CB2 cannabinoid receptors in mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Receptor-independent effects of natural cannabinoids in rat peritoneal mast cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

The cannabinoid CB2 receptor selective agonist JWH133 reduces mast cell oedema in response to compound 48/80 in vivo but not the release of beta-hexosaminidase from skin slices in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

Clinical and histological evaluation of an analogue of palmitoylethanolamide, PLR 120 (comicronized Palmidrol INN) in cats with eosinophilic granuloma and eosinophilic plaque: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01674.X

10.1111/J.1365-2826.2008.01674.X

21 January 2018

Identifiers

DOI

1 reference

release_7lh36533srh67m2ulah5oieqmi

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7lh36533srh67m2ulah5oieqmi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference